Citi analysts raised their price target on Veeva Systems (NYSE:VEEV) from $256 to $273, while maintaining a Buy rating, ahead of the company’s upcoming Q2/25 earnings, scheduled to be released on Wednesday.
The increased optimism ahead results stems from positive trends in Life Sciences demand and resilient demand across Veeva’s product suite, as indicated by partner conversations.
Veeva’s strong pipeline visibility for the second half of the year supports the analyst’s outlook, which is considered conservative. The analysts expect a slight beat on billings and revenue, with steady guidance as new CFO Brian Van Wagener settles into his role. Despite no changes in estimates, the price target adjustment reflects continued confidence in Veeva’s double-digit growth prospects and margin improvement potential.